New Frontiers of Pharmaceutical Law Young Researchers Workshop, May 6 - 7 th, 2010, Sala del Rettorato, Piazza Tancredi, Lecce (Italy) For further information.

Slides:

Advertisements

Similar presentations

Contents: The Consortium Background Goal Objectives Methodology, dissemination strategies and timetable UNIVERSITA CATTOLICA DEL SACRO CUORE MILANO.

Advertisements

Sunday 25Monday 26Tuesday 27Wednesday 28Thursday 29Friday 30Saturday 31 Main topic of the day Arrival and introductionInstitutional and regulatory framework.

INTERNATIONAL CONFERENCE ON MANAGING IP IN UNIVERSITIES Istanbul, May 16, 2012 The Italian Road Map.

DESTINATION EUROPE ! Europe : a vibrant place for frontier research Prof Dr Kurt Deketelaere Secretary-General League of European Research Universities.

1 HAI conference Medicines for Europe and the World Setting priorities: missing the point A rational medicines policy for Europe A rational.

London Medicines Information Service (Northwick Park Hospital) - June 2008 Drug Promotion: The Pharmaceutical Representative. Making the most of Promotional.

© Safeguarding public health Expert Group on Innovation in the Regulation of Healthcare products Adaptive Licencing workshop at the Wellcome Trust October.

Fighting corruption in the Italian Public Sector Law November Prof. Fabio Cintioli Scuola Nazionale di Amministrazione.

LIMITED EDITION WORMIN’ UP Netval and its role in exploiting research results in Italy.

Pricing and Reimbursement Policies 27. Pricing Policies Patented Medicines Patented Medicine Prices Review Board (PMPRB) monitors and sets the price of.

Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.

Prof. A. De Wever SAFETY, EFFICACY, QUALITY AND RISK/BENFIT RATIO Source : Marc Czarka.

HEALTHatWORK An Inquiry into the Health and Safety at Work; a European Union Perspective Coordination and Support Action (Supporting) Project Coordinator:

‘EUsers - Services of general interest in the EU: a citizens’ perspective on public versus private provision’ 2014 – 2017 Jean Monnet Networks Creation.

Introduction to Regulation

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

The Italian venture capital and private equity market IFISE Meeting A.I.F.I. Italian Venture Capital and Private Equity Association Marco Vitale Milan,

Governance of the European Patent System: A Separation of Powers Approach Professor Peter Drahos The Australian National University, Canberra and Queen.

European Research Council For operational reasons : 25 panels in 3 main domains PE: Physical Sciences, Engineering (10 panels) LS: Life Sciences (9 panels)

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

Integrating IP Teaching in Law Curricula Dr Duncan Matthews Queen Mary University of London.

Page 1 EPS Economics and Political Science. Page 2 Overview  The two-year master’s degree in Economics and Political Science (EPS) at University of Milan.

“SPECIALS” LEGAL BACKGROUND & INTRODUCTION TO GN14 Presented by Rob Lowe Director of Quality Assurance Specialist Services – East of England.

Translation of Stem Cells therapies: How to Balance Hope and Uncertainties? E. Rial-Sebbag and A. Blasimme.

Presentation by Ida Ngueng Feze Esq. Centre of Genomics and Policy, McGill University.

Panel 3. Designing Pharmaceutical Markets: Pharmaceuticalisation, Regulation and Global Health 1. G. Bloom –‘ Addressing the challenge of unorganised markets.

Presidency of Council of Ministers National Committee for Biosafety, Biotechnology and Life Sciences (D.P.C.M. March 19, 2007)

AIM 2008 Conference Teaching and Transfer Processes Zürich, Switzerland, September 2008 The XIV Summer School of IE ‘FrancescoTurco’ Director ( ):

Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.

CAPACITIES OVER 50S AS RURAL DEVELOPMENT TOOL CAPACITIES OVER 50S AS RURAL DEVELOPMENT TOOL Grundtvig Project DINAMICA TEACHING TOOLS, METHODS AND CURRICULA.

Clinical Trial Review and Approval: New Regulations and their implications Siddika Mithani, Ph.D Clinical Trials & Special Access Programme Therapeutic.

Essential Medicines and the University Challenge: Promoting Local Research for Global Impact For more information, please visit: UAEM home page:

UNECE-e8-EBRD-WEC Clean Electricity Production Forum: Fostering Investment in Electricity Generation in Central and Eastern Europe and Central Asia Geneva,

European Standards on Confidentiality and Privacy in Healthcare Dr Colin M Harper Division of Psychiatry & Neuroscience Queen’s University.

Approaches to failing markets Daniel Gordon Office of Fair Trading BIICL Transaltantic Antitrust Dialogue 2 May 2007.

5th IgCLL Educational Workshop Program ____________________________________________________________ Immunoglobulin Sequence Analysis in Chronic Lymphocytic.

1 EU-funded health research activities against TB: FP6 actions and perspectives toward FP7 DG Research - European Commission 22 MARCH 2007.

Evidence, guidelines and practice: the way forward in a digital age SYDNEY 11 April, 2013 Bill Runciman Professor – Patient Safety & Healthcare Human Factors.

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Role of Regulation in Optimizing Medicine use KNH/UON Pharmacy Symposium Optimizing Medicine.

September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.

Board Structure and Auditors: The Italian Experiment and Lessons for the Future BIICL, London – 19 November 2004 Marco Ventoruzzo - Università L. Bocconi,

European Standards on Confidentiality and Privacy in Healthcare Dr Colin M Harper Division of Psychiatry & Neuroscience Queen’s University.

Victoria Maynard Habitat for Humanity Great Britain/ University College London.

Page 1 EPS Economics and Political Science. Page 2 What is EPS?  Taught entirely in English  Highly qualified interdisciplinary learning track.  Master.

WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.

PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM Privacy Regulation of the Pharmaceutical Sector 14 November 2003 Washington,

British Institute for International & Comparative Law Product Liability & Mass Torts in a Global Marketplace London – 7 June 2007 Regulation and Product.

Voluntary Standards and Government: Working Together A Positive Collaboration Benefits Both the Public and Private Sectors Presentation by Mary C. McKiel,

Using Australian Clinical Sites – Challenges for International Sponsors Prof A J (Tony) Webber Clinical Network Services Pty Ltd Brisbane, Australia.

MOSCOW, NOVEMBER 2007 JUSTICE AND HOME AFFAIRS AND EUROPEAN INTEGRATION PROF DR JAAP W. DE ZWAAN DIRECTOR ‘CLINGENDAEL’ AND PROFESSOR OF EU LAW THE NETHERLANDS.

Centre for Information and Innovation LawMarch 5, Reinventing the Law for Synthetic Biology? – A brief overview on some emerging legal challenges.

Practising medicine in the UK W Kuriyan. Routes into Medicine in UK Undergraduate degree Postgraduate entrance Foreign graduates 1.Non European Union.

COMPETITION POLICY IN BISMARCK AND BEVERIDGE HEALTHCARE SYSTEMS: HOW DO COMPETITION LAW, ECONOMIC REGULATION AND MERGER CONTROL OPERATE IN DUTCH AND ENGLISH.

CIPA Visit to ASPA 5 October 2016 Richard Mair Chairman, CIPA International Liaison Committee Supporting logos to go in this box if there aren’t any please.

Preventing Corruption & Bribery - Perspectives from the Regulators-

Paya Serai Coffee House

New Tracers: rules in Europe

DIRECTOR ‘CLINGENDAEL’ AND PROFESSOR OF EU LAW

Professional experience

The importance of dialogue between regulators

Trends in Retail Competition:

Challenges and Opportunities in Halal Industry

UGBS 101 Introduction to Business Administration

Board of Healthcare Funders

THE GOALS OF COMPETITION LAW AND THE ROLE OF LEGAL INSTITUTIONS

BioCapital Europe 2019, Amsterdam

Transformation in Occupational Health and Safety systems: countries that newly entered the EU – lessons learnt Dr. Ivan Kokalov, Vice-President Confederation.

3rd Workshop on Non-Clinical Safety Assessment of Biopharmaceuticals “Next generation therapies” WELCOME.

ALCESTE SANTUARI (Ph.D. Law – Cantab)

Presentation transcript:

New Frontiers of Pharmaceutical Law Young Researchers Workshop, May th, 2010, Sala del Rettorato, Piazza Tancredi, Lecce (Italy) For further information please contact prof. or Thursday, May 6 th, 15h30-16h15 Saluti e benvenuti Prof. Raffaele DE GIORGI Preside, Facoltà di giurisprudenza Prof.ssa Francesca LAMBERTI Direttrice, Dipartimento di Studi Giuridici, Università del Salento Prof.ssa Marie-Eve ARBOUR Università del Salento, Université Laval 16h15-17h00: Opening Lecture Dr. Duncan FAIRGRIEVE Director, Product Liability Forum, BIICL, London 17h30-19h00 Panel I — Health Policy and Regulation Chairman: Dr. Richard S. GOLDBERG (University of Aberdeen) “Regulating risks in pharmaceutical law : in search of an optimal interplay between products safety and products liability” Marco RIZZI, Instituto universitario europeo, Fiesole “The Constitutional Role of European Public Health Policy: The Case of the Influenza A H1N1 Vaccine” Anniek DE RUIJTER, University of Amsterdam “Market Regulation through “Private Attorney General” Actions” Francesco QUARTA, Università del Salento Friday, May 7 th, 9h00-13h30 Lecture : Dr. Peter FELDSCHREIBER Medicines and Healthcare Products Regulatory Agency, UK Panel II — Specific Issues in Pharmaceutical Law Chairman: Dr. Peter FELDSCHREIBER (MHRA, UK) “Hepatitis B vaccine and the risk of multiple sclerosis” Isabelle CHIVORET, Université de Nantes “The Challenge of Nanomedicine: At the Crossroads Between Governance and Regulation” Francesca FERRARI, Scuola Superiore Sant’Anna, Pisa “Pharmacovigilance: The Canadian Experience” Albina MULAOMEROVIC, Université Laval, Québec 11h00-11h30 Discussion and coffee break Panel III — IP and Competition Law Chairman: Prof. Cristoforo OSTI (Università del Salento) “Limiting parallel trade in the pharmaceutical sector: an objective justification” Anna Lisa BITETTO, Università di Siena “Competition in the public procurements of pharmaceuticals" Chiara SAMMARCO, Università del Salento “The legal protection of biotechnological inventions” Antonio DEL SOLE, Università degli Studi di Milano 13h00-14h30 Discussion and lunch Friday, May 7 th, 14h30-18h00 Panel IV — Professions and bioethics ChairLady: Prof.ssa Diana CERINI (Università di Milano Bicocca) “Clinical Trials on Vulnerable Human Subjects” Agnese QUERCI, Università di Genova “The debate about the off-label prescriptions of drugs: a comparison between Italian and foreign law” Lucca NOCCO and Benedetta GUIDI, Scuola Superiore Sant’Anna, Pisa “Bioethics and European Union: the advanced therapy medicinal products case” Aurélie MAHALATCHIMY, Université de Toulouse "The "compassionate exemption" in Spain: not asking for compassion " Francisco Miguel BOMBILLAR SÀENZ Universidad de Granada Discussion and Coffee break 17h15-18h00 Concluding Remarks Prof. Franz WERRO Université de Fribourg, Switzerland Georgetown University, Washington D.C.

New Frontiers of Pharmaceutical Law Young Researchers Workshop*, Lecce (Italy) May 6 th - 7 th, 2010 Sala del Rettorato, Piazza Tancredi The Faculty of Law, University of Salento, Lecce (Italy) in association with: Opinio Juris in Comparatione and the British Institute of International and Comparative Law Product Liability Forum For further information please contact prof. Marie-Eve Arbour or